Tumor Protein P53 Inducible Protein 13 (TP53I13) Peptide
TP53I13
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all TP53I13 products
- TP53I13 (Tumor Protein P53 Inducible Protein 13 (TP53I13))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-TP53I13 antibody (Catalog #: ARP51702_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TP53I13 (Tumor Protein P53 Inducible Protein 13 (TP53I13))
- Background
-
TP53I13 may act as a tumor suppressor. It inhibits tumor cell growth, when overexpressed. TP53I13 was up-regulated by genotoxic stresses of adriamycin and/or ultraviolet beam irradiation in a p53-dependent manner
Alias Symbols: DSCP1
Protein Size: 393 - Molecular Weight
- 42 kDa
- Gene ID
- 90313
- NCBI Accession
- NM_138349, NP_612358
- UniProt
- Q8NBR0
-
You are here:
